Home / CHGA Knockout Cell Lines

CHGA Knockout Cell Lines

Gene: CHGA

Official Full Name: chromogranin Aprovided by HGNC

Gene Summary: The protein encoded by this gene is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. It is found in secretory vesicles of neurons and endocrine cells. This gene product is a precursor to three biologically active peptides; vasostatin, pancreastatin, and parastatin. These peptides act as autocrine or paracrine negative modulators of the neuroendocrine system. Two other peptides, catestatin and chromofungin, have antimicrobial activity and antifungal activity, respectively. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO04580 CHGA Knockout cell line (A549) Human CHGA 1:3~1:4 Negative Online Inquiry

Background

CHGA Gene Knockout Cell Lines are genetically engineered cell lines in which the chromogranin A (CHGA) gene has been deliberately disrupted. This strategic alteration provides invaluable models for researchers investigating the roles of CHGA in neuroendocrine signaling, hormone secretion, and tumor biology. By employing advanced gene editing technologies such as CRISPR/Cas9, these knockout cell lines enable precise studies into the gene's functional contributions, cellular mechanisms, and interactions with various signaling pathways.

The primary function of CHGA is as a precursor to several neuropeptides and hormones, playing a critical role in regulating hormone storage and secretion. By utilizing CHGA knockout cell lines, researchers can closely examine the impact of CHGA absence on cellular behavior, providing insight into its role in diseases such as neuroendocrine tumors, metabolic disorders, and neurodegenerative diseases. This model system is pivotal for both basic and applied research, offering opportunities to assess therapeutic targets and drug responses more accurately.

Notably, the CHGA Gene Knockout Cell Lines present distinct advantages over traditional models. They eliminate confounding factors related to CHGA expression, thereby ensuring clearer interpretations of experimental outcomes. These knockout models are also compatible with high-throughput screening, which opens avenues for drug discovery and the development of targeted treatments.

For researchers and clinicians focused on neuroendocrine physiology and pathology, these cell lines represent a powerful tool that can enhance understanding and devise novel therapeutic interventions. By contributing significantly to the elucidation of gene function and disease mechanisms, CHGA Gene Knockout Cell Lines hold immense potential for advancing scientific knowledge and improving clinical outcomes.

Our company specializes in the development of cutting-edge biological products designed to facilitate innovative research and drive scientific discovery. Leveraging our expertise in genetic engineering and cellular biology, we strive to provide high-quality resources that empower scientists and researchers in their quest for knowledge and breakthroughs.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.